FDA staff sends mixed message on JJ drug Xarelto
WASHINGTON (Reuters) - U.S. drug reviewers had mixed opinions about whether Johnson Johnson blood thinner Xarelto reduced the risk of new heart attacks and strokes in people with heart problems, setting the stage for heated debate by outside experts later this week. (Source: Reuters: Health)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div

'Commit more cash' to Global Fund
MPs are urging the UK to give more money to the Global Fund which fights AIDS, tuberculosis (TB) and malaria. (Source: BBC News | Health | UK Edition)